Detail akcie Cutera online

Business Summary: Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Cutera Inc revenues decreased 29% to $38.8M. Net loss decreased 19% to $22.8M. Revenues reflect Products-Product Segment decrease of 30% to $24.3M, Skincare-Product segment decrease of 48% to $4.2M, United States segment decrease of 37% to $14.1M, Japan segment decrease of 41% to $7.6M. Lower net loss reflects Selling, General & Administrative Expens decrease of 19% to $22.6M (expense).